AVTX

Avalo Therapeutics, Inc. Common Stock

$15.95 -1.12%

Recent alerts on AVTX

All signals →

News Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

SEC filing AVTX Reports Q1 2026 Net Loss $19.6M, Diluted EPS -$1.25, $431.3M Financing

Insider trade Sale by Christopher Ryan Sullivan (Chief Financial Officer)

Scanner Large up move: 34.1% (2.4x normal daily movement)

Insider trade Sale by Paul Varki (Chief Legal Officer)

Insider trade Sale by Mitchell Chan

Insider trade Sale by Mittie Doyle (Chief Medical Officer)

Insider trade Sale by Christopher Ryan Sullivan (Chief Financial Officer)

Scanner Large up move: 34.1% (2.6x normal daily movement)

News Avalo Therapeutics prices $375M public offering; shares jump

SEC filing AVTX Reports 42.2% HiSCR75 Response, 42.9% Response, Phase 2 LOTUS Trial Success, Advances to Phase 3 Program

Insider trade Sale by Christopher Ryan Sullivan (Chief Financial Officer)

Short interest Short interest 20.7% of float

Insider trade Sale by Mittie Doyle (Chief Medical Officer)

Insider trade Sale by Mittie Doyle (Chief Medical Officer)

Scanner Unusual volume (z=3.2)

Get push alerts for AVTX

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS